Novel melatonin-based therapies: potential advances in the treatment of major depression.
about
Agomelatine augmentation of escitalopram therapy in treatment-resistant obsessive-compulsive disorder: a case reportAntidepressants for the treatment of depression in people with cancerMelatonin and agomelatine for preventing seasonal affective disorderPsychological therapies for preventing seasonal affective disorderMelatonin and agomelatine for preventing seasonal affective disorderParoxetine versus other anti-depressive agents for depressionAntidepressants for the treatment of depression in patients with cancerFluoxetine versus other types of pharmacotherapy for depressionSecond-generation antidepressants for seasonal affective disorderNine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology reviewMelatonin has multiorgan effectsMT1 and MT2 Melatonin Receptors: A Therapeutic PerspectiveLower melatonin secretion in older females: gender differences independent of light exposure profilesAgomelatine in the treatment of major depressive disorder: an assessment of benefits and risksThe Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsEfficacy and tolerability of agomelatine in the treatment of depressionAgomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSEA randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashesComparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.Out of the lab and into the bathroom: evening short-term exposure to conventional light suppresses melatonin and increases alertness perception.Biomarkers and clinical staging in psychiatryManipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression.Clinical classification in mental health at the cross-roads: which direction next?Ambulatory sleep-wake patterns and variability in young people with emerging mental disordersDelayed circadian phase is linked to glutamatergic functions in young people with affective disorders: a proton magnetic resonance spectroscopy studySleep-wake cycle in young and older persons with a lifetime history of mood disorders.Markers of Oxidative Stress and Neuroprogression in Depression Disorder.The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trialChronotype and Improved Sleep Efficiency Independently Predict Depressive Symptom Reduction after Group Cognitive Behavioral Therapy for Insomnia.Circadian profiles in young people during the early stages of affective disorder.Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses.N-acetylserotonin: neuroprotection, neurogenesis, and the sleepy brainReduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressantsTherapeutic applications of melatonin.Differentiating nonrestorative sleep from nocturnal insomnia symptoms: demographic, clinical, inflammatory, and functional correlates.Agomelatine efficacy in the night eating syndrome.Successful Treatment with Agomelatine in NES: A Series of Five Cases.Agomelatine as monotherapy for major depression: an outpatient, open-label study.Agomelatine for Depression in Schizophrenia: A Case-SeriesUnveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology.
P2860
Q21285010-ED79BC52-02D8-4B4C-887B-A54011EDAC9AQ24187358-F88A874D-E2EF-43A4-81CC-79AFC249A96BQ24187803-BC8C94FC-2E81-4ADD-8DA2-29ACA73A51B9Q24187809-F2BF4F4F-8ED5-4D52-B309-6A4892BD417AQ24194188-84C62E2C-91A1-48CB-A569-1F8CE0B169D7Q24197507-2765A7A3-3E37-4C3C-8389-3AC5EE4A130FQ24198949-C3BC63B0-3C28-427B-87BA-0131A991C893Q24201165-E7CD247F-94E7-407E-914A-FF2A4DC2F0CBQ24234341-95C3E23F-9F7E-4941-BFEA-29572A3CF02AQ28067988-9E734093-6C8E-4EA2-865F-86F09A60B9A5Q28077901-F3BEA50B-67BE-4038-A638-1850BE692227Q28083929-7129C04F-90F0-4EB4-B4F8-40B71089A1AAQ28384854-137D4692-7263-4431-96CB-3DB8EAB7ACECQ28651497-33541989-76E2-4D58-9105-4B7A8B5575F8Q30486707-2A72F2EC-BE90-4F1D-A732-F0D4B1D25BDBQ33583450-82622CAE-DE0E-41B2-9286-44BE71B53389Q33610031-694D6CD8-3E8B-4A9E-85AB-45D17CDA8D64Q33768639-D87D642D-2178-4A69-B233-A717E5D7884FQ34040072-21B16720-0130-4F84-AA0D-E09215A5DBB3Q34324919-CB595BF8-E1B9-4BA7-B9BF-0F84CDFF0A2AQ34447051-7C9F736D-3D4B-407D-A45B-1D2E567894ADQ34632470-FC889ECD-B93B-4B9B-BC8C-CE276C4C6C2AQ34721893-8953D8D4-40EE-4A0B-AC77-6E37A4AA556BQ34765088-29530B81-E09A-4ECC-B410-A9FEFF952755Q34769551-BFAD4A0C-AA73-4E9B-9B03-72C535AE0496Q35105974-AC1EBF45-24EB-4FF9-8F06-032692D85FBBQ35677056-4768A878-A316-44E3-9FCC-02F845F68E73Q35753913-6AFAACD6-5875-43D1-BC16-5E0E5B865690Q35976658-DCF7AF7F-9BDC-47B9-8F7F-FFAA9B3C7D5EQ36001615-726B047E-0A3E-4825-B05D-ED1D95ED97E0Q36061629-D6C6ED17-EA39-448F-BC4F-3641BD858242Q36173713-6883E936-8B15-4A7B-9E7B-45471ED0ADD6Q36619321-8D21ECD3-DBDF-41F3-A1FB-B63F9BC1EA4CQ36671329-A7F87D29-A119-44FF-9489-2DAEC1AB71EBQ36761269-7E49C232-770D-406D-9353-789DCC8DAF62Q36896415-FA39576A-EDAA-423A-B2A1-4FDD6013D565Q37226594-285DD150-004F-4E65-B663-5F33F2FBACC6Q37254909-035B1F4B-9754-4A66-BD7F-E56D0EB41172Q37299879-891FE85B-0094-417F-A8FA-929978EACB96Q37404821-1AE00E18-E77B-490B-84B2-1FBA086F2CC8
P2860
Novel melatonin-based therapies: potential advances in the treatment of major depression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel melatonin-based therapies: potential advances in the treatment of major depression.
@ast
Novel melatonin-based therapies: potential advances in the treatment of major depression.
@en
Novel melatonin-based therapies: potential advances in the treatment of major depression.
@nl
type
label
Novel melatonin-based therapies: potential advances in the treatment of major depression.
@ast
Novel melatonin-based therapies: potential advances in the treatment of major depression.
@en
Novel melatonin-based therapies: potential advances in the treatment of major depression.
@nl
prefLabel
Novel melatonin-based therapies: potential advances in the treatment of major depression.
@ast
Novel melatonin-based therapies: potential advances in the treatment of major depression.
@en
Novel melatonin-based therapies: potential advances in the treatment of major depression.
@nl
P1433
P1476
Novel melatonin-based therapies: potential advances in the treatment of major depression.
@en
P2093
Ian B Hickie
P304
P356
10.1016/S0140-6736(11)60095-0
P407
P577
2011-05-17T00:00:00Z